Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII

Summary

Catabolism of coagulation factorVIII (FVIII) is mediated by lowdensity lipoprotein receptor-related protein (LRP). The ligandbinding sites of LRP are formed by complement-type repeats (CR), and CR clusters II and IV bind most of LRP ligands. FVIII contains two major LRP-binding sites located in the A2 and A3 domains. This study was aimed to identify specific complementtype repeats of LRP involved in interaction with the A2 site and to probe their functional importance in A2 catabolism. We generated individual LRP clusters II, III and IV, along with nine overlapping CR triplets encompassing clusters II and IV in a baculovirus expression system and studied their interaction with isolated A2. In surface plasmon resonance (SPR) assay, A2 bound to clusters II and IV with K_Ds 22 and 39 nM, respectively, and to the majority of CR triplets with affinities in the range of K_Ds 25–90 nM. Similar affinities were determined for A2 interaction with a panel of CR doublets overlapping cluster II (CR 3–4, 4–5, 5–6 6–7 and 7–8). These LRP fragments inhibited the binding of ¹²⁵I-A2 to LRP in solid-phase assay,LRP-mediated internalization of ¹²⁵I-A2 in cell culture and ¹²⁵I-A2 clearance from the mouse circulation. Point mutations of critical A2 residues of the LRPbinding site resulted in differential reduction or abolishment of its binding to LRP fragments. We conclude that A2 interacts with LRP via multiple binding sites spanning CR 3–8 in cluster II and CR 23–29 in cluster IV, and the minimal A2-binding unit of LRP is formed by two adjacent CR.

Keywords

Coagulation factor VIII - low-density lipoprotein receptor-related protein

• References

• 1 Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-10370.
• 2 Fay PJ. Factor VIII structure and function. Int J Hematol 2006; 83: 103-108.
• 3 Saenko EL, Yakhyaev AV, Mikhailenko I. et al. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. J Biol Chem 1999; 274: 37685-37692.
• 4 Lenting PJ, Neels JG, van Den Berg BM. et al. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein. J Biol Chem 1999; 274: 23734-23739.
• 5 Schwarz HP, Lenting PJ, Binder B. et al. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Wille- brand factor-deficient mice. Blood 2000; 95: 1703-1708.
• 6 Bovenschen N, Herz J, Grimbergen JM. et al. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. Blood 2003; 101: 3933-3939.
• 7 Strickland DK, Ranganathan S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemost 2003; 1: 1663-1670.
• 8 Bu G, Rennke S. Receptor-associated protein is a folding chaperone for low density lipoprotein receptorrelated protein. J Biol Chem 1996; 271: 22218-2224.
• 9 Obermoeller LM, Warshawsky I, Wardell MR. et al. Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone. J Biol Chem 1997; 272: 10761-10768.
• 10 Turecek PL, Schwarz HP, Binder BR. In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor. Blood 2000; 95: 3637-3638.
• 11 Bovenschen N, Mertens K, Hu L. et al. LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo. Blood 2005; 106: 906-912.
• 12 Marchetti G, Lunghi B, Legnani C. et al. Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women. Haematologica 2006; 91: 1261-1263.
• 13 Russell DW, Brown MS, Goldstein JL. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J Biol Chem 1989; 264: 21682-21688.
• 14 Fass D, Blacklow S, Kim PS. et al. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 1997; 388: 691-693.
• 15 Dolmer K, Huang W, Gettins PG. Characterization of the calcium site in two complement-like domains from the low-density lipoprotein receptor-related protein (LRP) and comparison with a repeat from the lowdensity lipoprotein receptor. Biochemistry 1998; 37: 17016-17023.
• 16 Neels JG, van Den Berg BM, Lookene A. et al. The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties. J Biol Chem 1999; 274: 31305-31311.
• 17 Andersen OM, Christensen LL, Christensen PA. et al. Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor- associated protein (RAP). A conserved acidic residue in the complement- type repeats is important for recognition of RAP. J Biol Chem 2000; 275: 21017-21024.
• 18 Huang W, Dolmer K, Gettins PG. NMR solution structure of complement-like repeat CR8 from the low density lipoprotein receptor-related protein. J Biol Chem 1999; 274: 14130-14136.
• 19 Andersen OM, Petersen HH, Jacobsen C. et al. Analysis of a two-domain binding site for the urokinase- type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoproteinreceptor- related protein. Biochem J 2001; 357: 289-296.
• 20 Lazic A, Dolmer K, Strickland DK. et al. Dissection of RAP-LRP interactions: binding of RAP and RAP fragments to complement-like repeats 7 and 8 from ligand binding cluster II of LRP. Arch Biochem Biophys 2006; 450: 167-175.
• 21 Sarafanov AG, Makogonenko EM, Pechik IV. et al. Identification of coagulation factor VIII A2 domain residues forming the binding epitope for low-density lipoprotein receptor-related protein. Biochemistry 2006; 45: 1829-1840.
• 22 Bovenschen N, Boertjes RC, van Stempvoort G. et al. Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII. J Biol Chem 2003; 278: 9370-9377.
• 23 Saenko EL, Scandella D. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von Willebrand factor. J Biol Chem 1997; 272: 18007-18014.
• 24 Lethagen S, Berntorp E, Nilsson IM. Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand’s disease type III. Ann Hematol 1992; 65: 253-259.
• 25 Bovenschen N, van SG, Voorberg J. et al. Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor- related protein within the A2 domain. J Thromb Haemost 2006; 4: 1487-1493.
• 26 Murphy JE, Mei B, Pan C. et al. Towards a new therapy for hemophilia A: Evaluation of multiple approaches to prolong the in vivo efficacy of recombinant factor VIII. Blood. 2006: 108: Abstract 1606.
• 27 Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. J Biol Chem 1992; 267: 13246-13250.
• 28 Fay PJ, Beattie TL, Regan LM. et al. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis. J Biol Chem 1996; 271: 6027-6032.
• 29 Brinkman HJ, Koster P, Mertens K. et al. Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation. Biochem J 1997; 323: 735-740.
• 30 Saenko EL, Shima M, Gilbert GE. et al. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem 1996; 271: 27424-27431.
• 31 Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266: 8957-8962.
• 32 Lollar P, Fay PJ, Fass D. Factor VIII and factor VIIIa. Methods Enzymol 1999; 222: 128-143.
• 33 Ashcom JD, Tiller SE, Dickerson K. et al. The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin. J Cell Biol 1990; 110: 1041-1048.
• 34 Williams SE, Ashcom JD, Argraves WS. et al. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor- related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J Biol Chem 1992; 267: 9035-9040.
• 35 Ulery PG, Beers J, Mikhailenko I. et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer’s disease. J Biol Chem 2000; 275: 7410-7415.
• 36 Sarafanov A, Saenko E. High-throughput optimization of protein expression in the baculovirus system based on determination of relative expression efficiency of viral stocks. Anal Biochem 2004; 328: 98-100.
• 37 Sarafanov AG, Ananyeva NM, Shima M. et al. Cell surface heparan sulfate proteoglycans participate in factor viii catabolism mediated by low density lipoprotein receptor-related protein. J Biol Chem 2001; 276: 11970-11979.
• 38 Horn IR, van Den Berg BM, van der Meijden PZ. et al. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding. J Biol Chem 1997; 272: 13608-13613.
• 39 Leyte A, Van Schijndel HB, Niehrs C. et al. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1991; 266: 740-746.
• 40 Chappell DA, Fry GL, Waknitz MA. et al. The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J Biol Chem 1992; 267: 25764-25767.
• 41 Kounnas MZ, Chappell DA, Wong H. et al. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J Biol Chem 1995; 270: 9307-9312.
• 42 Orlando RA, Exner M, Czekay RP. et al. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Proc Natl Acad Sci USA 1997; 94: 2368-2373.
• 43 Quinn KA, Grimsley PG, Dai YP. et al. Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J Biol Chem 1997; 272: 23946-23951.
• 44 Fisher C, Beglova N, Blacklow SC. Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol Cell 2006; 22: 277-283.
• 45 Jensen GA, Andersen OM, Bonvin AM. et al. Binding site structure of one LRP/RAP complex – implications for a common ligand/receptor binding motif. J Mol Biol 2006; 362: 700-716.
• 46 Sarafanov A, Makogonenko E, Andersen O. et al. Identification of regions in low-density lipoprotein receptor- related protein responsible for interaction with A2 and A1/A3-C1-C2 portions of coagulation factor VIII. J Thromb Haemost. 2005: 3 Abstract OR248.
• 47 Sarafanov A, Makogonenko E, Andersen O. et al. Fragments of activated coagulation factor VIII bind to multiple sites within low-density lipoprotein receptorrelated protein. Blood 2005; 106: 298a (Abstract 1019).
• 48 Meijer AB, Rohlena J, van der Zwaan C. et al. Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha(2)- macroglobulin, factor IXa and factor VIII. Biochim Biophys Acta 2007; 1774: 714-722.
• 49 Fay PJ, Koshibu K. The A2 subunit of factor VIIIa modulates the active site of factor IXa. J Biol Chem 1998; 273: 19049-19054.
• 50 Harpel PC. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. J Clin Invest 1981; 68: 46-55.